Patients with lung cancer confirmed by pathology
Conditions
Interventions
Case group:None
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Aged between 18 and 75, with no gender restrictions; 2.Pathological confirmation of lung cancer, or strong suspicion of lung cancer with plans for biopsy or surgery; 3.Suspected recurrence/metastasis after surgery or treatment; 4.Before any assessment is conducted, the subject or their legal guardian must understand and sign a written informed consent form;
Exclusion criteria
Exclusion criteria: 1. Suffering from other diseases that are unsuitable for participation in this study: (1) Cardiovascular system diseases: NYHA class III-IV heart failure; acute coronary syndrome or severe arrhythmia within the past 6 months; systolic blood pressure =180 mmHg or diastolic blood pressure =110 mmHg and uncontrolled; (2) Liver dysfunction: Child-Pugh class C liver failure; ALT or AST =3 times the upper limit of normal, or total bilirubin =2 times the upper limit of normal; (3) Kidney dysfunction: eGFR <30 mL/min/1.73m²; requiring dialysis treatment; (4) Hematologic diseases: neutrophils <1.5×10?/L; platelets <75×10?/L; active bleeding or severe coagulation dysfunction; (5) Malignant tumors: having had any malignant tumor other than the study-related tumor within the past 5 years; (6) Respiratory system diseases: severe or very severe chronic obstructive pulmonary disease (GOLD class III-IV); (7) Immune system diseases or immunodeficiency states requiring long-term systemic immunosuppressive therapy; (8) Other severe diseases that, according to the investigator’s assessment, may significantly affect the safety of the study or the reliability of the results. 2. Suffering from claustrophobia. 3. History of drug abuse or alcoholism. 4. Pregnant or breastfeeding women. 5. Any condition that the study investigator believes may cause harm or have potential hazards during any part of this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety;Internal radiation dose;Optimal imaging time window; | — |
Countries
China
Contacts
Public ContactLi Huo
Peking Union Medical College Hospital
Outcome results
None listed